Stoke Therapeutics, Inc. (STOK) stock forecast — our track record
29 completed STOK stock predictions — wins and misses, nothing deleted. Each forecast was published before the outcome was known.
How our STOK forecasts have done
Lyra published 29 STOK stock forecasts from September 27, 2025, with each prediction released before its outcome was known. Every call used the short term (0 to 3 months) horizon. The closed record ran through May 7, 2026, so the results could be scored against what the stock actually did afterward.
Overall, 21 targets were reached. None of them missed, and 8 were partial results. The average success score was 81%. The short term calls also averaged 81%, because all 29 forecasts used that same horizon. Average peak gain was 35.5%. Most of them hit, but not all calls reached the original target.
The best call was published on October 1, 2025. It predicted 40% growth, and the stock rose 64.9% at its peak. The target was reached in 13 days, and the call scored 100%. The weakest call was published on October 27, 2025. It predicted 35% growth, and the stock rose 12.8% at its peak. It did not reach the target and scored 50%. The track record was strong overall, with many full hits and no misses.
Written from the closed signals below; refreshed when new signals close.
Closed STOK signals
Peak result is the highest point inside the signal’s measurement window — labelled as peak because it is not a realized return.
Share this receipt
The full public record for this symbol — wins and misses. Paste the link anywhere — it unfurls as the card above.
See what we’re calling today.
Every published signal is scored against what the stock actually did — the same way STOK was. No deleted misses, no cherry-picking.